Global Interventional Oncology Market Growth (Status and Outlook) 2023-2029

Global Interventional Oncology Market Growth (Status and Outlook) 2023-2029

Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.

LPI (LP Information)' newest research report, the “Interventional Oncology Industry Forecast” looks at past sales and reviews total world Interventional Oncology sales in 2022, providing a comprehensive analysis by region and market sector of projected Interventional Oncology sales for 2023 through 2029. With Interventional Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Oncology industry.

This Insight Report provides a comprehensive analysis of the global Interventional Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Interventional Oncology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Oncology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Oncology.

The global Interventional Oncology market size is projected to grow from US$ 1652.5 million in 2022 to US$ 2181.3 million in 2029; it is expected to grow at a CAGR of 4.0% from 2023 to 2029.

Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.

This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Oncology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Ablation Devices
Embolization Devices
Support Devices

Segmentation by application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical

Please note: The report will take approximately 2 business days to prepare and deliver.